Themis Medicare

237.49
+14.26
(6.39%)
Market Cap
2,185.86
Eps
4.73
PE Ratio (TTM)
38.72
Dividend Yield
0.22
Industry
Healthcare
52 Week High
317.00
52 Week low
180.55
PB Ratio
5.42
Debt to Equity
0.29
Sector
Pharmaceuticals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
5.66 %
Net Income Growth
-23.55 %
Cash Flow Change
37.29 %
ROE
-31.26 %
ROCE
-30.37 %
EBITDA Margin (Avg.)
-32.53 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
215
236
220
213
186
205
234
401
366
387
444
Expenses
184
194
184
185
182
166
181
299
287
330
357
EBITDA
31
41
36
28
5
39
53
102
79
56
87
Operating Profit %
9 %
16 %
15 %
12 %
1 %
18 %
21 %
24 %
19 %
13 %
14 %
Depreciation
12
12
8
7
8
8
9
10
11
12
11
Interest
15
12
12
12
12
13
13
9
10
9
10
Profit Before Tax
5
17
18
11
-13
27
41
95
73
53
66
Tax
-1
2
2
0
-2
2
6
22
16
10
13
Net Profit
5
15
16
11
-11
25
36
73
57
44
53
EPS in ₹
7.34
19.12
17.66
12.30
-11.69
26.97
38.86
79.22
6.18
4.73
5.80

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
277
275
289
305
314
350
371
428
514
566
Fixed Assets
122
117
124
126
123
116
133
144
162
168
Current Assets
134
133
124
143
150
181
186
214
265
293
Capital Work in Progress
4
6
9
3
3
8
3
3
3
3
Investments
0
0
23
24
27
36
45
56
70
89
Other Assets
151
151
134
153
162
191
191
225
279
307
Total Liabilities
277
275
289
305
314
350
371
428
514
566
Current Liabilities
136
130
124
125
147
155
128
110
139
155
Non Current Liabilities
82
71
12
12
9
12
24
31
35
34
Total Equity
59
74
152
169
158
183
219
288
339
378
Reserve & Surplus
51
66
143
160
149
174
209
278
330
369
Share Capital
9
9
9
9
9
9
9
9
9
9

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-5
5
-0
-1
-3
2
16
1
-8
-3
Investing Activities
-6
-7
-4
0
-4
-6
-16
-16
-24
-16
Operating Activities
19
26
-2
8
11
0
57
34
16
22
Financing Activities
-18
-13
5
-9
-10
7
-26
-18
0
-9

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
67.26 %
67.22 %
67.18 %
67.18 %
67.18 %
67.18 %
67.18 %
67.18 %
67.16 %
67.16 %
67.16 %
67.16 %
67.15 %
67.15 %
67.15 %
67.15 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.05 %
0.00 %
0.03 %
0.05 %
0.10 %
0.10 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.59 %
22.99 %
22.56 %
22.30 %
22.20 %
22.35 %
22.32 %
23.16 %
23.12 %
22.63 %
22.33 %
22.67 %
23.31 %
23.42 %
23.65 %
24.24 %
No of Share Holders
5,858
6,822
6,511
6,212
5,891
5,915
6,126
6,362
5,927
6,007
6,970
11,244
11,295
11,322
14,270
17,773

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 1.75 4.3 5 5 0.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 6.22 4.59 4.24 2.29 0.22 0.00
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,752.75 4,20,543.44 35.94 49,887.20 12.06 9,648 13.77 44.79
6,123.50 1,62,559.68 78.25 8,184.00 0.89 1,600 64.53 60.08
1,436.80 1,16,037.99 23.45 26,520.70 14.17 4,155 47.38 46.67
3,114.70 1,05,415.60 56.43 10,785.70 11.59 1,656 13.54 35.94
2,483.00 1,02,440.36 51.56 10,615.60 19.57 1,942 -16.38 42.73
1,227.55 1,02,428.11 18.95 28,905.40 12.36 5,578 1.69 41.25
2,185.10 99,683.73 36.66 20,141.50 19.94 1,936 73.53 56.12
977.00 98,309.06 22.90 19,831.50 13.82 3,831 29.92 51.89
1,191.75 69,217.03 18.82 29,559.20 17.55 3,169 8.66 48.98
5,117.95 61,192.77 28.08 12,978.40 9.84 1,812 14.16 43.89

Corporate Action

Technical Indicators

RSI(14)
Neutral
34.33
ATR(14)
Volatile
12.15
STOCH(9,6)
Oversold
12.39
STOCH RSI(14)
Oversold
13.67
MACD(12,26)
Bearish
-1.51
ADX(14)
Strong Trend
27.70
UO(9)
Bearish
35.15
ROC(12)
Downtrend But Slowing Down
-13.41
WillR(14)
Oversold
-92.02